416P Prognostic impact of liquid biopsy (LB) biomarkers at relapse on second-line (2L) treatment (Tx) after progression to endocrine therapy (ET) in metastatic breast cancer (mBC): Ancillary analysis of the MAGNETIC.1 study. - Dri, A.; Foffano, L.; Molteni, E.; Franzoni, A.; Lay, L.; Cucciniello, L.; Da Ros, L.; Buriolla, S.; Bolzonello, S.; Noto, C.; Russo, S.; Spazzapan, S.; et al. (Annals of Oncology, 2024)